|
|
Books > Medicine > Other branches of medicine > Pharmacology
Postmortem Toxicology addresses the various aspects of the practice
of forensic postmortem toxicology from a viewpoint of elements
which must be taken into consideration for proper interpretation of
the toxicological result, not in a vacuum but in a more holistic
and global sense. The volume examines pre-analytical factors,
storage containers/conditions, prior medical interventions and
therapy, along with information from the scene investigation and
anatomical findings. This reference also provides explanation of
the complicating conditions for the interpretation of the
toxicological results due to postmortem decomposition, embalming
artifacts and the postmortem redistribution of drugs. Tolerance is
also discussed as an aid to interpreting results from a
habitual/chronic user of medications and/or drugs of abuse. The
book is geared towards the current practitioner; however, it is
written to be used as a valuable reference for a graduate or
post-graduate level courses in forensic toxicology or forensic
pathology.
Shortlisted for the BMA Book Awards and Macavity Awards 2016
Fourteen novels. Fourteen poisons. Just because it's fiction
doesn't mean it's all made-up ... Agatha Christie revelled in the
use of poison to kill off unfortunate victims in her books; indeed,
she employed it more than any other murder method, with the poison
itself often being a central part of the novel. Her choice of
deadly substances was far from random - the characteristics of each
often provide vital clues to the discovery of the murderer. With
gunshots or stabbings the cause of death is obvious, but this is
not the case with poisons. How is it that some compounds prove so
deadly, and in such tiny amounts? Christie's extensive chemical
knowledge provides the backdrop for A is for Arsenic, in which
Kathryn Harkup investigates the poisons used by the murderer in
fourteen classic Agatha Christie mysteries. It looks at why certain
chemicals kill, how they interact with the body, the cases that may
have inspired Christie, and the feasibility of obtaining,
administering and detecting these poisons, both at the time the
novel was written and today. A is for Arsenic is a celebration of
the use of science by the undisputed Queen of Crime.
This volume explores techniques that are currently used to
understand solid target-specific models in computational
toxicology. The chapters are divided into four sections and discuss
topics such as molecular descriptors, QSAR and read-across;
molecular and data modeling techniques to comply with both
scientific and regulatory sides; computational toxicology in drug
discovery; and strategies on how to predict various human-health
toxicology endpoints. Written in the highly successful Methods in
Molecular Biology series format, chapters include introductions to
their respective topics, lists of the methods and software tools
used, step-by-step, readily reproducible computational protocols,
and tips on troubleshooting and avoiding known pitfalls.
Comprehensive and cutting-edge, Computational Toxicology: Methods
and Protocols is a valuable resource for researchers who are
interested in learning more about this expanding field.
The History of Alternative Test Methods in Toxicology uses a
chronological approach to demonstrate how the use of alternative
methods has evolved from their conception as adjuncts to
traditional animal toxicity tests to replacements for them. This
volume in the History of Toxicology and Environmental Health series
explores the history of alternative test development, validation,
and use, with an emphasis on humanity and good science, in line
with the Three Rs (Replacement,Reduction, Refinement) concept
expounded by William Russell and Rex Burch in 1959 in their now
classic volume, The Principles of Humane Experimental Technique.
The book describes the historical development of technologies that
have influenced the application of alternatives in toxicology and
safety testing. These range from single cell monocultures to
sophisticated, miniaturised and microfluidic organism-on-a-chip
devices, and also include molecular modelling, chemoinformatics and
QSAR analysis, and the use of stem cells, tissue engineering and
hollow fibre bioreactors. This has been facilitated by the wider
availability of human tissues, advances in tissue culture,
analytical and diagnostic methods, increases in computational
processing, capabilities, and a greater understanding of cell
biology and molecular mechanisms of toxicity. These technological
developments have enhanced the range and information content of the
toxicity endpoints detected, and therefore the relevance of test
systems and data interpretation, while new techniques for
non-invasive diagnostic imaging and high resolution detection
methods have permitted an increased role for human studies. Several
key examples of how these technologies are being harnessed to meet
21st century safety assessment challenges are provided, including
their deployment in integrated testing schemes in conjunction with
kinetic modelling, and in specialized areas, such as inhalation
toxicity studies. The History of Alternative Test Methods in
Toxicology uses a chronological approach to demonstrate how the use
of alternative methods has evolved from their conception as
adjuncts to traditional animal toxicity tests to replacements for
them. This volume in the History of Toxicology and Environmental
Health series explores the history of alternative test development,
validation, and use, with an emphasis on humanity and good science,
in line with the Three Rs (Replacement, Reduction, Refinement)
concept expounded by William Russell and Rex Burch in 1959 in their
now-classic volume, The Principles of Humane Experimental
Technique. The book describes the historical development of
technologies that have influenced the application of alternatives
in toxicology and safety testing. These range from single cell
monocultures to sophisticated miniaturised and microfluidic
organism-on-a-chip devices, and also include molecular modelling,
chemoinformatics and QSAR analysis, and the use of stem cells,
tissue engineering and hollow fibre bioreactors. This has been
facilitated by the wider availability of human tissues, advances in
tissue culture, analytical and diagnostic methods, increases in
computational processing capabilities, and a greater understanding
of cell biology and molecular mechanisms of toxicity. These
technological developments have enhanced the range and information
content of the toxicity endpoints detected, and therefore the
relevance of test systems and data interpretation, while new
techniques for non-invasive diagnostic imaging and high resolution
detection methods have permitted an increased role for human
studies. Several key examples of how these technologies are being
harnessed to meet 21st century safety assessment challenges are
provided, including their deployment in integrated testing schemes
in conjunction with kinetic modelling, and in specialised areas,
such as inhalation toxicity studies.
New Look to Phytomedicine: Advancements in Herbal Products as Novel
Drug Leads is a compilation of in-depth information on the
phytopharmaceuticals used in modern medicine for the cure and
management of difficult-to-treat and challenging diseases. Readers
will find cutting-edge knowledge on the use of plant products with
scientific validation, along with updates on advanced herbal
medicine in pharmacokinetics and drug delivery. This authoritative
book is a comprehensive collection of research based, scientific
validations of bioactivities of plant products, such as
anti-infective, anti-diabetic, anti-cancer, immune-modulatory and
metabolic disorders presented by experts from across the globe.
Step-by-step information is presented on chemistry, bioactivity and
the functional aspects of biologically active compounds. In
addition, the pharmacognosy of plant products with mechanistic
descriptions of their actions, including pathogenicity is updated
with information on the use of nanotechnology and molecular tools
in relation to herbal drug research.
Technological innovations have become the impetus for continuous
developments in medical research. With the assistance of new
technologies, effective drug delivery techniques have been improved
for optimal patient care. Recent Advances in Drug Delivery
Technology is a pivotal reference source for the latest scholarly
research on the application of pharmaceutical technology to
optimize techniques for drug delivery in patients. Focusing on
novel approaches in pharmaceutical science, this book is ideally
designed for medical practitioners, upper-level students,
scientists, and researchers.
Androgens are critical regulators of prostate differentiation
and function, as well as prostate cancer growth and survival.
Therefore, androgen ablation is the preferred systemic treatment
for disseminated prostate cancer. Androgen action is exerted in
target tissues via binding the androgen receptor (AR), a nuclear
receptor transcription factor.
Historically, the gene expression program mediated by the AR has
been poorly understood. However, recent gene expression profiling
and more traditional single-gene characterization studies have
revealed many androgen-regulated genes that are important mediators
of androgen action in both normal and malignant prostate tissue.
This book will focus on the androgen-regulated gene expression
program, and examine how recently identified androgen-regulated
genes are likely to contribute to the development and progression
of prostate cancer. Recent studies that have attempted to unravel
how these genes are deregulated in androgen depletion independent
prostate cancer will be included
Advanced Issue Resolution in Safety Pharmacology not only discusses
unique issues that may emerge during the development of new
medicines, but also provides detailed insights on how to resolve
them. The book employs a valuable strategy that integrates
preclinical findings with the clinical resolution of those
findings. In addition, it introduces key interdisciplinary topics
in an accessible and systematic format. Edited and written by
leaders in the field of safety pharmacology, this book considerably
advances the discussion on issue resolution topics, thus raising
them to the next level of importance by providing scientists with
an indispensable resource on solving safety issues.
|
|